Furthermore, Bcl-xl can suppress VDAC1-mediated mitochondrial Ca2+ uptake in breast cancer cells, leading to changes in mitochondrial ATP generation and increased ROS production, ultimately promoting cancer cell migration [179]. This evidence concerns the gene BCL2L1 and breast carcinoma.